fda warning letter hims compounded semaglutide 2025 & Hers stock crashes after announces plans to take 'decisive steps' against GLP-1 compounds Beyond the Headlines: FDA Warning

P values of less than 0.05 were considered statistically significant

[3] It was discovered by Chugai Pharmaceutical Co., then was licensed to Lilly in 2018

In her office, parents are often leading the conversation about their teens taking GLP-1s

Nickelodeon has ordered 10 episodes of Lip Sync Battle Shorties for season two

Peer review Peer review information Nature Communications thanks Paul Yen and the other, anonymous, reviewers for their contribution to the peer review of this work

Additionally, certain early signals including a possible association between GLP-1 use and elevated kidney cancer risk, as well as questions regarding long-term thyroid safety underscore the importance of individualised clinical assessment and ongoing medical supervision